BTG Plc (BTG) - Financial and Strategic SWOT Analysis Review

Date: August 23, 2016
Pages: 65
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B389D64935DEN
Leaflet:

Download PDF Leaflet

BTG Plc (BTG) - Financial and Strategic SWOT Analysis Review
BTG Plc (BTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

BTG plc (BTG) is a healthcare company that develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops its own products and acquires or in-licenses them from others. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, the UK, Guernsey, Australia and Germany. BTG is headquartered in London, the UK.

BTG Plc Key Recent Developments

Aug 18, 2016: CMS grants Vistogard New Technology Add-on Payment status effective 1 October 2016
Jul 27, 2016: BTG Announces Appointment of Non-executive Director
Jul 14, 2016: BTG: Annual General Meeting
Jul 14, 2016: BTG: Annual General Meeting
Jun 09, 2016: BTG Joins Global Liver Institute Partnership Network to Transform Care for Liver Cancer Patients

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

BTG Plc - Key Facts
BTG Plc - Key Employees
BTG Plc - Key Employee Biographies
BTG Plc - Major Products and Services
BTG Plc - Pharmaceutical Pipeline Products Data
BTG Plc, Pipeline Products by Therapy Area
BTG Plc, Pipeline Products by Development Phase
BTG Plc - History
BTG Plc - Company Statement
BTG Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

BTG Plc - Business Description
BTG Plc - Corporate Strategy
BTG Plc - SWOT Analysis
SWOT Analysis - Overview
BTG Plc - Strengths
Strength - Focused Research and Development Activities
Strength - Enhanced Performance across Business Divisions
BTG Plc - Weaknesses
Weakness - Legal Challenges
BTG Plc - Opportunities
Opportunity - Acquisition of Galil Medical
Opportunity - New Product Launches
Opportunity - Changing Demographics
BTG Plc - Threats
Threat - Competitive Pressures
Threat - Government Regulations
Threat - Uncertain R&D Outcomes
BTG Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

BTG Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016
BTG Plc, Medical Equipment, Deals By Type, 2010 to YTD 2016
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
BTG Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
BTG Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 18, 2016: CMS grants Vistogard New Technology Add-on Payment status effective 1 October 2016
Jul 27, 2016: BTG Announces Appointment of Non-executive Director
Jul 14, 2016: BTG: Annual General Meeting
Jul 14, 2016: BTG: Annual General Meeting
Jun 09, 2016: BTG Joins Global Liver Institute Partnership Network to Transform Care for Liver Cancer Patients
May 17, 2016: BTG: Final Results
Apr 08, 2016: Edison Issues ADR Update on BTG
Apr 05, 2016: BTG: Close Period Update
Nov 10, 2015: BTG Announces Interim Results For The Six Months Ended 30 September 2015
Nov 10, 2015: BTG: Interim Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

BTG Plc, Key Facts
BTG Plc, Key Employees
BTG Plc, Key Employee Biographies
BTG Plc, Major Products and Services
BTG Plc, Number of Pipeline Products by Therapy Area
BTG Plc, Number of Pipeline Products by Development Stage
BTG Plc, Pipeline Products By Therapy Area and Development Phase
BTG Plc, History
BTG Plc, Subsidiaries
BTG Plc, Key Competitors
BTG Plc, Ratios based on current share price
BTG Plc, Annual Ratios
BTG Plc, Interim Ratios
BTG Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016
BTG Plc, Medical Equipment, Deals By Type, 2010 to YTD 2016
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
BTG Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
BTG Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

BTG Plc, Pipeline Products by Therapy Area
BTG Plc, Pipeline Products by Development Phase
BTG Plc, Performance Chart (2012 - 2016)
BTG Plc, Ratio Charts
BTG Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016
BTG Plc, Medical Equipment, Deals by Type, 2010 to YTD 2016
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Vernalis Plc
Transgene SA
Immupharma Plc
F. Hoffmann-La Roche Ltd.
Baxter International Inc.
Skip to top


Ask Your Question

BTG Plc (BTG) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: